通过形淋巴瘤激酶接收体的结构基础
Tongqing Li1,2, Steven E Stayrook1,2, Yuko Tsutsui1,2
1Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA.
Nature
|November 25, 2021
概括
无细胞淋巴瘤激酶 (ALK) 的结构揭示了其富含甘氨酸的域如何调节受体活性. 这一发现为ALK驱动的癌症提供了新的治疗策略,包括儿童神经母细胞瘤.
科学领域:
- 分子生物学
- 结构生物学
- 癌症研究
背景情况:
- 无细胞淋巴瘤激酶 (ALK) 是一种对神经系统发育至关重要的受体激酶.
- 在发育后,ALK影响学习,记忆和能量消耗,抑制预防肥胖.
- 异常的ALK信号驱动各种癌症,尤其是儿童神经母细胞瘤.
研究的目的:
- 通过其细胞外甘氨酸丰富域 (GRD) 阐明ALK调节的结构基础.
- 了解ALK如何响应调节性联体并形成二元复合体.
- 确定ALK相关恶性瘤的潜在治疗点.
主要方法:
- 用X射线结晶学来确定ALK GRD的结构.
- 设计ALK GRD的融合蛋白及其配体以捕获二元复合体.
- 聚甘氨酸延伸环 (PXL) 的位点定向突变和抗体相互作用研究.
主要成果:
- 揭示了ALK GRD的晶体结构,详细说明了它在调节受体活动中的作用.
- 证明GRD中的重复性甘氨酸形成了刚性螺旋,将连接位与PXL分开.
- 确定PXL是ALK二分化和受体间信号传递的关键媒介.
结论:
- ALK的非典型结构,特别是PXL,是其联体介导调节的核心.
- 通过突变或抗体破坏PXL功能可以消除ALK激活.
- 这些发现为儿童神经母细胞瘤等由ALK驱动的癌症提供了新的治疗途径.
相关概念视频
Receptor Tyrosine Kinases
15.0K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.0K
Transducer Mechanism: Enzyme-Linked Receptors
3.1K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.1K
Amplifying Signals via Enzymatic Cascade
13.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
13.3K
Ligand Binding Sites
14.1K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.1K
Enzyme-linked Receptors
80.6K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
80.6K
PI3K/mTOR/AKT Signaling Pathway
4.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.1K


